TrialBlood2014

Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).

Julie E Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.